Comunicados de prensa U.S. FDA Salud y ciencias de la vida — Feed RSS y monitoreo en vivo
PPN World sigue el feed RSS de U.S. FDA en tiempo real — 14 comunicados indexados en los últimos 30 días, el más reciente llegó hace 2 d. Síguelo con alertas de búsquedas guardadas, resúmenes con IA y búsqueda de texto completo, o conecta la URL RSS de abajo a tu propio lector.
Sobre este feed
U.S. FDA forma parte de los más de 1,200 feeds de comunicados que PPN World monitorea de forma continua — una fuente en inglés centrada en el sector Salud y ciencias de la vida, clasificada bajo «Estados Unidos» en nuestro índice por país. Cada comunicado se deduplica, se geolocaliza y se enriquece con un resumen de IA, y puedes añadir alertas de búsquedas guardadas sobre cualquier palabra clave que publique. En los últimos 30 días, U.S. FDA ha publicado 14 comunicados, sobre todo los jueves, con cobertura reciente centrada en fda-approval, drug, screwworm.
Sigue U.S. FDA en tiempo real en PPN World
Cada comunicado de U.S. FDA llega al cockpit segundos después de publicarse — deduplicado, clasificado, con alertas de búsquedas guardadas y resúmenes con IA, junto a más de 1,200 feeds. Prueba gratis de 7 días, sin tarjeta.
Iniciar la prueba gratis →Últimos comunicados de U.S. FDA
- FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Productshace 2 d
The U.S. Food and Drug Administration today announced it is taking action, consistent with the Trump administration’s commitment to protecting vulnerable patients and maintaining access to critical me…
- FDA Grants Accelerated Approval to a New Breast Cancer Treatmenthace 2 d
The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new t…
- FDA Approves First Drug to Treat Alexander Diseasehace 3 d
The U.S. Food and Drug Administration has approved Zanvastro (zilganersen) injection for the treatment of Alexander disease in pediatric and adult patients.
- FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Catshace 3 d
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, the generic version of Capstar
- FDA Seeks Public Input to Advance Development of Botanical Drug Productshace 3 d
The U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
- FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorderhace 8 d
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cell…
- FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adultshace 10 d
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
- FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattlehace 10 d
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of b…
- FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancerhace 11 d
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced…
- FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugarhace 12 d
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Iahace 17 d
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older…
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Devicehace 18 d
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention.
Los comunicados más recientes de esta fuente se transmiten en vivo para los miembros de PPN World.